Toggle light / dark theme

Melinjo Seed Extracts May Help Improve Diabetes And Obesity

Researchers from Kumamoto University have found that Melinjo seed extracts may help to improve diabetes and obesity by stimulating the production of adiponectin which is a hormone that works to help improve both conditions; individual genotype differences were also discovered that were responsible for variations in its efficacy.

Melinjo fruit contain high levels of antioxidant and antibacterial properties as well as high levels of polyphenols such as resveratrol that has been shown to induce adiponectin and may help to improve lifestyle related diseases such as metabolic syndrome. A type of resveratrol called Gnetin C which is found in MSE has higher antioxidant activity and has been shown to stay in the blood longer than resveratrol, but the exact mechanisms of how they exert their biological activity remains unknown.

Genetic analysis was used to find that differences in the type of DsbA-L gene affects adiponectin activation; meaning that DsbA-L induction may promote adiponectin activation and help to improve lifestyle related diseases. Their recent research has attempted to determine whether MSE enhances the function of DsbA-L; whether MSE promotes adi[onectin activation; and whether MSE has a therapeutic effect on either obesity and diabetes.

Vigilantes de parque usan gafas de realidad aumentada para detectar a personas con fiebre en China

Los vigilantes del parque Xixi Wetland de Hangzhou (China) emplean gafas de realidad aumentada que les permiten detectar qué personas tienen fiebre desde una distancia segura para minimizar los contagios de covid-19.

Suscríbete a nuestro canal de eventos en vivo: https://www.youtube.com/channel/UCEIhICHOQOonjE6V0SLdrHQ

RT en Twitter: https://twitter.com/ActualidadRT
RT en Facebook: https://www.facebook.com/ActualidadRT
RT en Vkontakte: http://vk.com/actualidadrt

Vea nuestra señal en vivo: http://actualidad.rt.com/en_vivo

RT EN ESPAÑOL: DESDE RUSIA CON INFORMACIÓN

#RTenEspañol #China #Coronavirus

Belgian-Dutch Study: Why in times of COVID-19 you can not walk/run/bike close to each other

What is a safe distance when running, biking and walking during COVID-19 times? It is further than the typical 1–2 meter as prescribed in different countries!

In a lot of countries walking, biking and jogging are welcome activities in these times of COVID-19. However, it is important to note that you need to avoid each other’s slipstream when doing these activities. This comes out of the result of a study by the KU Leuven (Belgium) and TU Eindhoven (Netherlands).

The typical social distancing rule which many countries apply between 1–2 meters seems effective when you are standing still inside or even outside with low wind. But when you go for a walk, run or bike ride you better be more careful. When someone during a run breathes, sneezes or coughs, those particles stay behind in the air. The person running behind you in the so-called slip-stream goes through this cloud of droplets.

Germany Touts Green Stimulus in Post Covid-19 Policy Push

👏Europe’s largest economy is looking to make its post-virus recovery compatible with its ambition of becoming carbon-neutral by 2050.

The EU has similarly pledged to make its stimulus plan aligned with its climate commitments.


Germany’s green energy shift may get a financial shot in the arm when the impact of the coronavirus ebbs, according to a senior member of Chancellor Angela Merkel’s cabinet.

When the virus’ acute phase is over, the government plans a stimulus package that advances the nation technologically and helps the economy’s move toward climate neutrality, Finance Minister Olaf Scholz said in an interview with Funke Mediengruppe. Such a package “makes sense,” said the Social Democrat without adding details.

The Kitui County Textile Center (KICOTEC), a Kenyan based industry producing masks to help curb COVD-19 receives international media recognition from the Washington Post Newspaper

The Kenyan factory has achieved a great milestone through its ability to make 30,000 surgical masks daily which is a major turnaround from its initial garment making business. I am glad in the stimulus package money will be given to small business to make things needed to fight coronavirus instead of sourcing them outside. The economic investment will help the economy just as Clinton invested in small businesses.

Amid confusion over virus symptoms, Israeli scientist creates a sniff test tool

An Israeli scientist is urging people to ask a simple question daily to save lives from coronavirus: can I smell? There is widespread confusion about how to identify coronavirus symptoms, as several of them are similar to symptoms of flu and the common cold. But Noam Sobel says that there is one highly unusual pattern, a sudden inability to smell, and he has built a website to help people keep tabs on their odor-assessing abilities. People are signing up from all over the world, at an average rate of 200 per hour.


Smell garlic and toothpaste and save lives from coronavirus: It’s not a folk cure, but a Weizmann Institute initiative, and 200 people an hour are joining.

Whistleblower doctors say coronavirus reinfection even deadlier

The doctor added that the virus has “outsmarted all of us,” since he says it’s able to hide symptoms for up to 24 days — which contradicts current guidance that the incubation period is two weeks.


Chinese doctors sounding the alarm on the coronavirus say the illness could be even deadlier for patients who catch it again, according to a report.

The whistleblowing physicians working to fight the virus in Wuhan, the epicenter of the outbreak, revealed that medically cleared patients have been getting reinfected, the Taiwan News reported.

“It’s highly possible to get infected a second time,” one of the doctors, who declined to be identified, told the outlet.

A guide to the vaccines and drugs that could fight coronavirus

The global race to make a vaccine and treatment for the Covid-19 coronavirus is well underway as the epicenter of the pandemic is now shifting toward the United States.

Many of the vaccine and drug development efforts are building on past efforts to deal with other viral outbreaks, including coronaviruses like MERS and SARS — which means researchers had a head start with Covid-19. In the US, a phase 1 clinical trial of a vaccine is already underway.